Cargando…
Economic Burden and Health-Related Quality of Life Associated with Current Treatments for Anaemia in Patients with CKD not on Dialysis: A Systematic Review
BACKGROUND: The cost and health-related quality of life (HRQoL) burden associated with treatments for anaemia of chronic kidney disease (CKD) is not well characterized among non-dialysis-dependent (NDD) patients. OBJECTIVE: Our objective was to review the literature on costs and HRQoL associated wit...
Autores principales: | Pergola, Pablo E., Pecoits-Filho, Roberto, Winkelmayer, Wolfgang C., Spinowitz, Bruce, Rochette, Samuel, Thompson-Leduc, Philippe, Lefebvre, Patrick, Shafai, Gigi, Bozas, Ana, Sanon, Myrlene, Krasa, Holly B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861396/ https://www.ncbi.nlm.nih.gov/pubmed/30968369 http://dx.doi.org/10.1007/s41669-019-0132-5 |
Ejemplares similares
-
Severity of memory impairment in the elderly: Association with health care resource use and functional limitations in the United States
por: Aigbogun, Myrlene Sanon, et al.
Publicado: (2017) -
Nephrologists’ Perspectives on Gender Disparities in CKD and Dialysis
por: Tong, Allison, et al.
Publicado: (2021) -
Patient and Care Partner Burden in CKD Patients With and Without Anemia: A US-Based Survey
por: Michalopoulos, Steven N., et al.
Publicado: (2022) -
Anaemia management with subcutaneous epoetin delta in patients with chronic kidney disease (predialysis, haemodialysis, peritoneal dialysis): results of an open-label, 1-year study
por: Frei, Ulrich, et al.
Publicado: (2009) -
The societal economic burden of autosomal dominant polycystic kidney disease in the United States
por: Cloutier, Martin, et al.
Publicado: (2020)